The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
The FTSE 100 ( ^FTSE) outperformed against European stocks on Thursday amid news that the UK housing market is continuing to ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Europe's main equity indices were little changed in midday deals after yet more record-highs Wednesday on Wall Street ...
The German telecommunications group said Thursday that expectations of faster growth mean it aims to have 15 billion euros ($16.41 billion) in available cash by 2027 to either increase its stake in ...
GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies ...
LONDON — UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts ...
The concerns surrounding Zantac also prompted UK health authorities to advise doctors in 2019 to cease prescribing specific formulations of the drug as a precautionary measure. Reports indicated that ...
GSK agreed to pay $2.2 billion to 10 plaintiff firms over liability cases related to its discontinued heartburn medicine Zantac allegedly causing cancer. The British pharmaceutical giant said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback